How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Hepatitis C virus infection increases the risk of adverse outcomes following joint arthroplasty: A meta-analysis of observational studies - ScienceDirect
Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients - ScienceDirect
Clinical pathways for patients with newly diagnosed hepatitis C – What actually happens - Irving - 2006 - Journal of Viral Hepatitis - Wiley Online Library
The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK | PLOS ONE
Diagnostic reliability of Architect anti‐HCV assay: Experience of a tertiary care hospital in India - Fletcher - 2018 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers - Clinical Therapeutics
Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention | BMC Medicine | Full Text
Hepatitis C–associated late-onset schizophrenia: a nationwide, population-based cohort study | JPN
HCV testing sequence for clinical routine and preselected samples with... | Download Scientific Diagram
How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy | BMC Infectious Diseases | Full Text
Modelling the impact of different testing strategies for HCV infection in Switzerland - ScienceDirect
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia
PDF) Performance evaluation and comparison of the newly developed Elecsys anti-HCV II assay with other widely used assays
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text
How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays
Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials - Asahina - 2020 - Hepatology Research - Wiley Online Library
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text
Updating the Signal-to-cutoff Level to Reduce Anti-hepatitis C Virus False Positivity | Jundishapur Journal of Microbiology | Full Text
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study | BMJ Open
Diagnosis and Management of Hepatitis C Virus Infection - ScienceDirect
High false discovery rate of the Architect anti‐HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing - Lucey - Vox Sanguinis - Wiley Online Library
